Jaguar Health Inc

NASDAQ:JAGX 1:00:00 PM EDT

0.12

0.00 (-3.17%)

4:58:11 PM EDT: $0.12 +0.01 (+5.52%)

Market Cap (Intraday)	16.31M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.65 Million
Adjusted EPS	-$0.10

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Jaguar Health Inc Stock, NASDAQ:JAGX

200 Pine Street, Suite 400, San Francisco, California 94104

United States of America

Phone: +1.415.371.8300

Number of Employees: 52

http://www.jaguar.health

Description

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.